Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
Titel:
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
Auteur:
Novello, S. Mazières, J. Oh, I.-J. de Castro, J. Migliorino, M.R. Helland, Å. Dziadziuszko, R. Griesinger, F. Kotb, A. Zeaiter, A. Cardona, A. Balas, B. Johannsdottir, H.K. Das-Gupta, A. Wolf, J.